The Clinical Significance of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis

BACKGROUND AND OBJECTIVE: Promoter status of O(6)-methylguanine-DNA methyltransferase (MGMT) has been widely established as a clinically relevant factor in glioblastoma (GBM) patients. However, in addition to varied therapy schedule, the prognosis of GBM patients is also affected by variations of ag...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Zhao, Yu-Hang, Wang, Ze-Fen, Cao, Chang-Jun, Weng, Hong, Xu, Cheng-Shi, Li, Kai, Li, Jie-Li, Lan, Jing, Zeng, Xian-Tao, Li, Zhi-Qiang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5873285/
https://ncbi.nlm.nih.gov/pubmed/29619003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados